Personalizing Care in Head and Neck Cancers: An Interdisciplinary Take on the Latest Evidence

Activity Description & Educational Objectives

In this activity, two experts in head and neck cancers discuss the highly nuanced management of head and neck cancers by walking through two patient cases: a 68-year-old man with laryngeal cancer, and a 57-year-old woman with oropharynx cancer.

Upon completion of this activity, participants will be able to:

• Discuss and apply the latest guideline recommendations and clinical trial data on novel strategies with chemotherapy, radiotherapy, and targeted agents into practice for early-stage and locally advanced/metastatic squamous-cell carcinoma of the head and neck (SCCHN).
• Effectively prevent and manage treatment-related adverse events and morbidity in patients with SCCHN undergoing treatment in different disease settings.
• Demonstrate improved awareness of the potential role and use of established and emerging prognostic and predictive factors that can help guide the management of SCCHN.
• Develop individualized treatment plans for patients with SCCHN that are based on latest evidence regarding the benefits and risks associated with different treatment modalities, patient characteristics and preferences, and safety considerations, among other factors.

Target Audience

This activity has been designed to meet the educational needs of oncologists, radiation oncologists, pathologists, otolaryngologists, advanced practice oncology nurses, and other clinicians involved in the management of head and neck cancers.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME/CNE credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Internet
Release and Expiration Dates: October 31, 2012 - October 30, 2013
Time to Complete: 45 minutes

Faculty & Disclosure / Conflict of Interest Policy

In accordance with ACCME requirements, Penn State College of Medicine has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.

Course Director and Moderator

Corey Langer, MD
Professor of Medicine
Abramson Cancer Center
University of Pennsylvania
Philadelphia, Pennsylvania

Corey Langer, MD, has a financial interest/relationship or affiliation in the form of:

Grant/Research Support from GlaxoSmithKline.

Advisory Board for Bristol-Myers Squibb; Boehringer Ingelheim; Eli Lilly and Company; and ImClone Systems Incorporated.

Interviewee

Jennifer R. Grandis, MD
Vice Chair for Research
UPMC Endowed Chair in Head and Neck Cancer Surgical Research
Department of Otolaryngology
Assistant Vice Chancellor for Research Program Integration in the Health Sciences
Professor of Otolaryngology & Pharmacology
University of Pittsburgh School of Medicine
Program Leader, Head & Neck Cancer Program
University of Pittsburgh Cancer Institute
American Cancer Society Clinical Research Professor
Pittsburgh, Pennsylvania

Jennifer R. Grandis, MD, currently has no financial interests/relationships or affiliations in relation to this activity.

Medical Director

Carmine DeLuca
PVI, PeerView Institute for Medical Education

Carmine DeLuca currently has no financial interests/relationships or affiliations in relation to this activity.

Other PVI staff who may potentially review content for this activity have disclosed no relevant financial relationships.

Penn State College of Medicine staff and faculty involved in the development and review of this activity have disclosed no relevant financial relationships.

Sponsorship, Credit & Support

Physicians

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Penn State College of Medicine and PVI, PeerView Institute for Medical Education. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Penn State College of Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Information about CME credit for this activity is available by contacting Penn State at 717-531-6483 or ContinuingEd@hmc.psu.edu. Reference course # G5198-13-T.

Nurses

The Institute for Advancement of Human Behavior is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This course is co-provided by IAHB and PVI, PeerView Institute for Medical Education. Maximum of 0.5 contact hour(s).

Note: Not all state nursing boards will accept programs less than 1.0 hour in length for credit. Please click here to find out the status of your state.

This CME/CNE activity is jointly sponsored by Penn State College of Medicine and PVI, PeerView Institute for Medical Education; the activity is also co-provided by the Institute for Advancement of Human Behavior.

This activity is supported by an educational grant from

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.